We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-19.4%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.07B
AUM Growth
-$277M
Cap. Flow
+$203M
Cap. Flow %
9.83%
Top 10 Hldgs %
48.47%
Holding
98
New
23
Increased
27
Reduced
24
Closed
17

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$50.5M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$48.9M
3
SHPG
Shire pic
SHPG
+$40.3M
4
CELG
Celgene Corp
CELG
+$33.1M
5
AMGN icon
Amgen
AMGN
+$26.5M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$57.3M
2
HALO icon
Halozyme
HALO
+$36M
3
TMO icon
Thermo Fisher Scientific
TMO
+$31.7M
4
UTHR icon
United Therapeutics
UTHR
+$30.6M
5
MRK icon
Merck
MRK
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 95.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRRA
51
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$7.66M 0.37%
28,427
+5,663
+25% +$1.81M
TVRD
52
Tvardi Therapeutics
TVRD
$22.9M
$7.54M 0.36%
33,683
– –
RGNX icon
53
Regenxbio
RGNX
$615M
$7.35M 0.36%
680,241
+329,541
+94% +$4.22M
AMSG
54
DELISTED
Amsurg Corp
AMSG
$7.19M 0.35%
+96,400
New +$6.79M
MNTA
55
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$6.29M 0.3%
680,552
+488,815
+255% +$5.26M
COLL icon
56
Collegium Pharmaceutical
COLL
$1.16B
$5.34M 0.26%
+294,400
New +$5.35M
MOH icon
57
Molina Healthcare
MOH
$10.5B
$5.22M 0.25%
+81,000
New +$4.81M
ABMD
58
DELISTED
Abiomed Inc
ABMD
$5.08M 0.25%
+53,600
New +$4.52M
ARAY icon
59
Accuray
ARAY
$29M
$4.46M 0.22%
+771,950
New +$4.27M
PRAH
60
DELISTED
PRA Health Sciences, Inc.
PRAH
$4.18M 0.2%
+97,800
New +$4.13M
RDY icon
61
Dr. Reddy's Laboratories
RDY
$9.77B
$4.16M 0.2%
460,525
-147,405
-24% -$1.32M
IART icon
62
Integra LifeSciences
IART
$1.54B
$4.08M 0.2%
+121,120
New +$3.77M
SCAI
63
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$3.67M 0.18%
+79,400
New +$3.33M
WMGI
64
DELISTED
Wright Medical Group Inc
WMGI
$3.02M 0.15%
+181,935
New +$3.37M
AGN
65
DELISTED
Allergan plc
AGN
$2.85M 0.14%
10,631
-9,561
-47% -$2.74M
ENTL
66
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$2.72M 0.13%
+149,665
New +$2.42M
ANAC
67
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$2.48M 0.12%
+46,500
New +$3.43M
TNDM icon
68
Tandem Diabetes Care
TNDM
$1.22B
$2.34M 0.11%
+26,869
New +$2.35M
LCI
69
DELISTED
Lannett Company, Inc.
LCI
$2.33M 0.11%
+32,489
New +$3.44M
XENT
70
DELISTED
Intersect ENT, Inc
XENT
$2.19M 0.11%
+115,540
New +$2.09M
PRGO icon
71
Perrigo
PRGO
$1.43B
$2.18M 0.11%
17,030
-12,791
-43% -$1.75M
NVAX icon
72
Novavax
NVAX
$1.21B
$2.13M 0.1%
+20,625
New +$2.21M
MNK
73
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.68M 0.08%
27,467
-25,687
-48% -$1.64M
AKRX
74
DELISTED
Akorn Inc
AKRX
$794K 0.04%
33,744
-30,659
-48% -$806K
CBPO
75
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$674K 0.03%
5,890
– –
1 2
3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Sectoral Asset Management held 98 positions worth $2.07B, down 12% from $2.35B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sectoral Asset Management deployed $203M of net new capital in Q1 2016, opening 23 new positions and adding to 27 existing holdings. Its largest new stake was Portola Pharmaceuticals, Inc.: 1,593,039 shares worth $32.5M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 97% a quarter earlier.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $31.7M trimmed.

  • Sectoral Asset Management's largest Q1 2016 buy was Portola Pharmaceuticals, Inc.: 1,593,039 shares worth $32.5M.
  • Sectoral Asset Management added most to Neurocrine Biosciences in Q1 2016, an estimated $48.9M increase.
  • Sectoral Asset Management's biggest Q1 2016 reduction was Thermo Fisher Scientific, cutting an estimated $31.7M.
  • Sectoral Asset Management fully exited Seagen Inc. Common Stock in Q1 2016, selling an estimated $57.3M.
  • Sectoral Asset Management's ten largest holdings make up 48% of its $2.07B portfolio in Q1 2016.
  • Sectoral Asset Management opened 23 new positions and closed 17 in Q1 2016.
  • Sectoral Asset Management's portfolio value fell 12% quarter-over-quarter to $2.07B.

Based on Sectoral Asset Management's 13F filing for Q1 2016, filed 13 May 2016.